Polycyclic compounds as soluble epoxide hydrolase inhibitors
US-2021261564-A1 · Aug 26, 2021 · US
US12486222B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12486222-B2 |
| Application number | US-202418915070-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 14, 2024 |
| Priority date | Mar 24, 2021 |
| Publication date | Dec 2, 2025 |
| Grant date | Dec 2, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to soluble epoxide hydrolase (sEH) inhibitors of formula (I)to processes for their obtention and to their therapeutic indications.
Opening claim text (preview).
The invention claimed is: 1 . A compound having the following structure: or a pharmaceutically acceptable salt thereof. 2 . A pharmaceutical or veterinary composition comprising a therapeutically effective amount of the compound of claim 1 .
linked by a carbon chain containing only aliphatic carbon atoms · CPC title
Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title
attached in position 4 · CPC title
containing a six-membered ring with oxygen as a ring hetero atom · CPC title
Non condensed piperidines, e.g. piperocaine · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.